When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Peptide Reclassification 2026: What It Means for Providers How did BPC 157 become the wellness industry's star peptide? Orthopedic Use of BPC 157 Sports Med Review Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York